This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Doug Brooks, PhD
Principal Consultant at Matapalo LLC


Mr. Metz is Founder and Principal Consultant at Metz Biotechnology Consulting, LLC; an alliance of experts in pharmaceutical development, facilities and equipment engineering, process control and optimization, GMP manufacturing, strategic sourcing, licensing and contracts development. With 38 years of experience in the pharmaceutical industry, the past 14 years have been focused in the field of oligonucleotide development and manufacturing.  Prior to founding Metz Biotech, Mr. Metz was Senior Director of Operations at Agilent Technologies in Boulder CO., where he helped build a world-class oligonucleotide API CDMO boasting among the largest commercial scale capabilities in the industry. He previously worked in R&D, engineering and manufacturing at Merck & Co. Inc. and Lonza Inc.; and also founded several start-up companies; taking one public.

Agenda Sessions

  • Workshop Moderator’s Welcome and Opening Remarks

  • Closing Remarks and Discussion